SPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD (SPARK)
Acceptability of an Augmented Reality Virtual Coach for Physical Exercise Practice in Patients With Chronic Obstructive Pulmonary Disease: a Multicenter Study
Chronic obstructive pulmonary disease (COPD) is associated with dyspnea, reduced physical activity, muscle deconditioning, and impaired quality of life. Pulmonary rehabilitation is an effective non-pharmacological intervention, but access remains limited and long-term adherence to physical exercise is often difficult to maintain. Augmented reality may provide an innovative approach to support exercise practice by offering real-time visual and auditory guidance while allowing patients to remain anchored in their real environment.
The SPARK study is a multicenter, interventional, non-randomized, proof-of-concept study designed to assess the acceptability of an augmented reality virtual coach for physical exercise in adults with COPD. Participants will attend a single experimental session including baseline questionnaires, presentation of the augmented reality headset, a short immersive exercise session guided by a virtual coach, and post-immersion assessments. Acceptability will be evaluated using the Technology Acceptance Model 3 questionnaire before and after immersion. User experience will also be explored through focus group discussions analyzed according to UXive dimensions.
The study aims to determine whether this technology is acceptable to patients with COPD and to identify factors that may facilitate or limit its future integration into pulmonary rehabilitation pathways.
Visão geral do estudo
Status
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Angélique Picard
- E-mail: Angelique.picard@ch-havre.fr
Estude backup de contato
- Nome: Clement Medrinal, PhD
- Número de telefone: +33664615110
- E-mail: clement.medrinal@ch-havre.fr
Locais de estudo
-
-
-
Montivilliers, França, 76290
- Recrutamento
- Groupe Hospitalier du Havre
-
Contato:
- Clément Medrinal
- Número de telefone: 0664615110
- E-mail: clement.medrinal@ch-havre.fr
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age ≥ 18 years Diagnosis of chronic obstructive pulmonary disease (COPD) confirmed according to GOLD recommendations, defined by a post-bronchodilator FEV1/FVC ratio < 0.70 No exacerbation during the previous month, defined as hospitalization or major therapeutic modification related to worsening respiratory symptoms Written informed consent obtained before any study-related procedure Affiliation to a social security system
Exclusion Criteria:
- COPD exacerbation during the previous month Major motor disorders, disabling osteoarticular conditions, or significant functional dependence preventing safe participation in physical exercises Insufficient cognitive or language abilities to understand instructions, complete questionnaires, or participate in the semi-structured interview Photosensitive epilepsy Uncorrected or atypical visual and/or hearing impairment Patient under legal guardianship, curatorship, or incarcerated Pregnant or breastfeeding woman
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Augmented Reality Virtual Coach Session
Participants with chronic obstructive pulmonary disease will attend a single experimental session using an augmented reality headset with a virtual coach. After baseline questionnaires and headset presentation, participants will complete an approximately 20-minute guided exercise session including calf raises, sit-to-stand exercises, and stretching. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. Acceptability will be assessed before and after immersion using the TAM3 questionnaire, followed by a focus group exploring user experience. |
Participants will use an augmented reality headset delivering a virtual coach-guided exercise session. The intervention consists of a single approximately 20-minute immersive session performed in a secured environment. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. The session includes calf raises, sit-to-stand exercises, and stretching. The intervention is designed to assess the acceptability and user experience of an augmented reality-based exercise support tool in adults with chronic obstructive pulmonary disease.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Global Acceptability Score of the Augmented Reality Virtual Coach
Prazo: Immediately after the augmented reality immersion session, during the single study visit
|
Acceptability will be assessed using the global score of the adapted Technology Acceptance Model 3 questionnaire completed immediately after the augmented reality immersion session. Items are rated on a 7-point Likert scale, with higher scores indicating greater acceptability. The mean global score will be compared with the theoretical neutral value of 4. |
Immediately after the augmented reality immersion session, during the single study visit
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Anaick Perrochon, PhD, Université Limoges
- Diretor de estudo: Bonnevie Tristan, PhD, ADIR Association
- Diretor de estudo: Benoit Borel, PhD, Université Limoges
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-A00566-45
- 2026-A00566-45 (Identificador de registro: ANSM)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .